Association of GPX1 polymorphism, GPX activity and prostate cancer risk

Human and Experimental Toxicology

Volumn 31, Issue 1, 2012, Pages 24-31

  Erdem, O ^a   Eken, A ^a   Akay, C ^a   Arsova Sarafinovska, Z ^b   Matevska, N ^c   Suturkova, L ^c   Erten, K ^a   Ozgok Y ^a   Dimovski, A ^c   Sayal, A ^a   Aydin, A ^d  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Institute of Public Health   (Macedonia)

^c SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^d YEDITEPE UNIVERSITY   (Turkey)

Author keywords

genetic polymorphism; glutathione peroxidase 1; oxidative stress; prostate cancer

Indexed keywords

GLUTATHIONE PEROXIDASE 1;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; CASE-CONTROL STUDIES; ERYTHROCYTES; GENE FREQUENCY; GENOTYPE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84856051350     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111411499     Document Type: Article

References (32)

1. Khandrika L, Kumar B, Koul S, et al. Oxidative stress in prostate cancer. Cancer Lett. 2009 ; 282: 125-136
2. Arsova-Sarafinovska Z, Matevska N, Eken A, et al. Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPx activity, and prostate cancer risk. Int Urol Nephrol. 2009 ; 41: 63-70
3. Trzeciak AR, Nyaga SG, Jaruga P, et al. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. Carcinogenesis. 2007 ; 28: 1359-1370 (Pubitemid 39162702)
4. Ravn-Haren G, Olsen A, Tjonneland A, et al. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis. 2006 ; 27: 820-825
5. Arthur JR. The glutathione peroxidases. Cell Moll Life Sci. 2000 ; 57: 1825-1835 (Pubitemid 32102578)
6. Chu FF, Doroshow JH, Esworthy RS. Expression, characterization, and tissue distribution of a new cellular selenium-dependent glutathione peroxidase, GSHPx-GI. J Biol Chem. 1993 ; 268: 2571-2576 (Pubitemid 23057880)
7. Takahashi K, Akasaka M, Yamamoto Y, et al. Primary structure of human plasma glutathione peroxidase deduced from cDNA sequences. J Biochem. 1990 ; 108: 145-148 (Pubitemid 20234496)
8. Maiorino M, Chu FF, Ursini F, et al. Phospholipid hydroperoxide glutathione peroxidase is the 18-kDa selenoproteins expressed in human tumor cell lines. J Biol Chem. 1991 ; 266: 7728-7732 (Pubitemid 21906425)
9. de Haan JB, Bladier C, Griffiths P, et al. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, GPX1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem. 1998 ; 273: 22528-22536 (Pubitemid 28399820)
10. Kote-Jarai Z, Durocher F, Edwards SM, et al. Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer. Prostate Cancer Prostatic Dis. 2002 ; 5: 189-192
11. Jablonska E, Gromadzinska J, Reszka E, et al. Association between GPx1 activity and plasma selenium concentration in humans. Eur J Nutr. 2009 ; 48: 383-386
12. Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003 ; 63: 3347-3351 (Pubitemid 36735893)
13. Knight JA, Onay UV, Wells S, et al. Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of breast cancer family registry. Cancer Epidemiol Biomark Prev. 2004 ; 13: 146-149 (Pubitemid 38116633)
14. Cox DG, Hankinson SE, Kraft P, et al. No association between GPX1 Pro198Leu and breast cancer risk. Cancer Epidemiol Biomark Prev. 2004 ; 13: 1821-1822 (Pubitemid 39482964)
15. Vogel U, Olsen A, Wallin H, et al. No association between GPX Pro198Leu and risk of basal cell carcinoma. Cancer Epidemiol Biomark Prev. 2004 ; 13: 1412-1413 (Pubitemid 39071570)
16. Hansen R, Saebo M, Skjelbred CF, et al. GPX Pro198Leu and OGG1 Ser326-Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Lett. 2005 ; 29: 85-91 (Pubitemid 41262543)
17. Yang P, Bamlet WR, Ebbert JO, et al. Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis. 2004 ; 25: 1935-1944 (Pubitemid 39405913)
18. Raaschou-Nielsen O, Sorensen O, Hansen RD, et al. GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. Cancer Lett. 2007 ; 247: 293-300 (Pubitemid 46240616)
19. Forsberg L, de Faire U, Marklund SL, et al. Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells Mol Dis. 2000 ; 26: 423-426 (Pubitemid 32037410)
20. Hansen RD, Krath BN, Frederiksen K, et al. GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer. Mut Res. 2009 ; 664: 13-19
21. Bostwick DG. Grading prostate cancer. Am J Clin Pathol. 1994 ; 102: 38-56
22. Poncz M, Solowiejczyk D, Harpel B, et al. Construction of human gene libraries from small amounts of pheripheral blood: analysis of beta-like globin genes. Hemoglobin. 1982 ; 6: 27-36 (Pubitemid 12149315)
23. Ratnasinghe D, Tangrea JA, Andersen MR, et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res. 2000 ; 60: 6381-6383
24. Eken A, Aydin A, Sayal A, et al. The effects of hyperbaric oxygen treatment on oxidative stress and SCE frequencies in humans. Clin Biochem. 2005 ; 38: 1133-1137 (Pubitemid 41797755)
25. Choi JY, Neuhouser ML, Barnett M, et al. Polymorphisms in oxidative stress- related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev. 2007 ; 16: 1115-1120 (Pubitemid 46984946)
26. Aydin A, Arsova-Sarafinovska Z, Sayal A, et al. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem. 2006 ; 39: 176-179 (Pubitemid 43255508)
27. Jung K, Seidel B, Rudolph B, et al. Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radic Biol Med. 1997 ; 23: 127-133 (Pubitemid 27217016)
28. Baker AM, Oberley LW, Cohen MB. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate. 1997 ; 32: 229-233 (Pubitemid 27374193)
29. Gate L, Paul J, Nguyen Ba G, et al. Oxidative stress induced in pathologies: the role of antioxidants. Biomed Pharmacother. 1990 ; 53: 169-180
30. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys. 2001 ; 389: 84-93 (Pubitemid 32911546)
31. Dragsted LO, Pedersen A, Hermetter A, et al. The 6-a-day study: effects of fruit and vegetables on markers of oxidative stress and antioxidative defense in healthy nonsmokers. Am J Clin Nutr. 2004 ; 79: 1060-1072 (Pubitemid 41095959)
32. Neve J. Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity. J Trace Elem Med Biol. 1995 ; 9: 65-73